Rheumatoid Arthritis Recruiting Phase 2 Trials for Methotrexate (DB00563)

Also known as: Rheumatoid Arthritis(RA) / Rheumatoid Arthritis, NOS / Rheumatoid Arthritis RA / Rhematoid Arthritis / Rheumatic Arthritis / Rheumatoid Arthritis (RA) / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Arthritis, Rheumatoid (RA) / Rheumatoid Arthritis(RA) / RA / Systemic rheumatoid arthritis / Rheumatoid arthritis (disorder) / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Rheumatoid arthritis NOS / Rheumatoid arthritis NOS (disorder)

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03589833Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RATreatment
NCT04247815Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RATreatment
NCT03813199Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid ArthritisTreatment
NCT02270632A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTXTreatment